The weight loss drug is so profitable that its parent company, Danish health care giant Novo Nordisk, is propping up Denmark’s entire economy. It’s poised to transform America’s too.This episode was produced by Victoria Chamberlin edited by Jolie Myers, fact-checked by Kim Eggleston, engineered by Rob Byers, and hosted by Noel King.Transcript at vox.com/todayexplainedSupport Today, Explained by making a financial contribution to Vox! bit.ly/givepodcastsLearn more about your ad choices. Visit podcastchoices.com/adchoices